We recently reported that dysregulation of lysosomal autophagy is involved in the pathogenesis of cardiomyopathy induced by DOX in a TLR2-dependent manner and that blocking TLR2 activity provides therapeutic benefits in mouse models of heart failure (Ma et al., 2012). This evidence concerns the gene TLR2 and heart failure.